Single Dose Bronchodilatory Study in Asthma
NCT01805687 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2014-09-03
Summary
Study to evaluate the bronchodilator effects of Zyflo CR in patients with chronic stable asthma.
Conditions
Interventions
- DRUG
-
Zileuton extended release
Sponsors & Collaborators
-
Cornerstone Therapeutics Inc.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2013-06-30
Countries
- United States
Study Locations
More Related Trials
-
Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI
NCT00565591 ·Status: COMPLETED ·Phase: PHASE1
-
Inhaled Iloprost in Mild Asthma
NCT01209533 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study to Evaluate the Bronchoprotective Effects of a Single Dose of N6022 in Patients With Mild Asthma
NCT01316315 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Single Dose Study of GSK1440115 in Patients With Asthma
NCT01424280 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma
NCT02334553 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
NCT02624505 ·Status: COMPLETED ·Phase: PHASE3
-
Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
NCT00319306 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacodynamic Bioequivalence Study of Albuterol Sulfate Inhalation Aerosol, 0.09 mg Albuterol Base/ Inhalation
NCT05292976 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients
NCT02227394 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy
NCT01711840 ·Status: COMPLETED
-
Trial of Simvastatin for the Treatment of Severe Asthma
NCT02433535 ·Status: WITHDRAWN ·Phase: PHASE2
-
Symbicort in Asthmatic Children - SEEDLING
NCT00651547 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 1 Study of CNTO 3157 in Healthy Volunteers and Patients With Asthma
NCT01195207 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Subjects > or = 12 Years of Age
NCT01156792 ·Status: COMPLETED ·Phase: PHASE2
-
BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma
NCT06154304 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM
NCT00652392 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
NCT01225913 ·Status: RECRUITING ·Phase: PHASE4
-
A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®
NCT00532922 ·Status: COMPLETED
-
Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma
NCT00573222 ·Status: COMPLETED
-
Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006
NCT01189396 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise
NCT01435902 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma
NCT01181895 ·Status: COMPLETED ·Phase: PHASE3
-
Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation
NCT01232335 ·Status: COMPLETED
-
Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT
NCT00646321 ·Status: COMPLETED ·Phase: PHASE3
-
Optimal Albuterol Regimens for Acute Asthma Exacerbations: DBRCT Pilot Study
NCT01196377 ·Status: COMPLETED ·Phase: NA